Congenital Hyperinsulinism

Research Updates (10)Clinical Trials (5)

Browse recruiting and upcoming clinical trials for congenital hyperinsulinism.

Patient-friendly, AI-assisted summaries based on official ClinicalTrials.gov ↗ records. Last updated: Oct 10, 2026

About this listHide

ClinicalTrials.gov is the complete and most up-to-date source. Trials may be missing, and trial information may have changed since our last check. Always verify important information in the official registry.

5 trials

Showing 5 trials

Recruiting
18F-DOPA II - PET Imaging Optimization
NCT04706910
Who can join AIPeople referred for 18F‑DOPA PET/CT for congenital hyperinsulinism, neuroblastoma, neuroendocrine tumors, brain tumors, Parkinson disease, or Lewy body dementia.
What is being studied AITests imaging optimization of 18F‑DOPA PET/CT including scanner and furosemide effects.
Study typeDiagnostic
CountriesCanada
View trial
Recruiting
Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma
NCT02021604
Who can join AIPeople aged 18 years or younger with congenital hyperinsulinism (HI) or with clinical insulinoma.
What is being studied AIWhether Fluorodopa F18 PET-CT can locate focal pancreatic lesions in congenital hyperinsulinism and insulinoma.
Study typeDiagnostic
CountriesUnited States
View trial
Not yet recruiting
Umbilical Cord Glucose
NCT07795047
Who can join AINewborns screened for congenital hyperinsulinism (CHI) and infants diagnosed with neonatal hyperinsulinism.
What is being studied AIWhether umbilical cord blood glucose can screen newborns for congenital hyperinsulinism.
Study typeScreening
CountriesNot posted yet
View trial
Recruiting
Role of Nutrient Transit in Hyperinsulinemic Hypoglycemia
NCT04615546
Who can join AIPeople with post-bariatric hypoglycemia and post-bariatric or non‑surgical control participants.
What is being studied AITests how food passage and gut hormones relate to low blood sugar after bariatric surgery.
Study typeOther
CountriesUnited States
View trial